-19 3 517 77,697 . 5 ..65 -19 . -19 . 3 81 . . . . 2 .. 2 38 . . . 2 .. 3 40 . . . . . 2 .. 59 517 77,697 75,846 8 . 239 . 78 . 51 . 38 . 35 . 29 . 6 . 3 38 2,029,190 .
3 31 .. 41 .. 4 5 .. . . 1 .. - 31 .. 78% 2,701 59% 8% 29% 4% 3 12.7 2.07 767 2 5 3 31 " 28 .. 3 41 31 .. 31 41 3 4 4 4 3 4 " . . 2 3 4
2 1,909,617 2 2,054 ( 107.56 ) 6 (0.31 ), 6 (0.31 ), 4 (0.21 ) 1 143,488 275,968 419,456 3,429 ( 817.49 ), 12 (2.86 ), 8 (1.91 ) , 9 (2.15 ) 5 ( 27 .. 2565, 16 .. 2564, 18 .. 2565 ) 5 ( 9 .. 25… [+95 chars]
1-2 2-5 7 25% 14 7 14 10-14 14 RT-PCR 4 9 (NIH) 19 (Long Covid) . . 29 4 45% 51% 19 19 : Yong Poovorawan, Thira… [+48 chars]
(FDA) (Sotrovimab) "" (Xevudy) (GSK) (Vir) -19 BA.2 3 4 FDA -19 GSK Vir BA.2 Vir GSK Vir BA.2 79 (MHRA) -19 -19 MHRA 5
. 21,088 91 """ BA.2" "" 5 ..65 COVID-19 -19 21,088 20,995 93 1 ..65 1,534,140 27,519 1 ..65 1,313,333 250,145 91 2563- 25,603 1,862 24 28.3 . () (.) Anan Jongkaewwattana ... XE XJ BA.2 BA.2 X R… [+178 chars]
(FDA) (Sotrovimab) "" (Xevudy) (GSK) (Vir) -19 BA.2 3 4 FDA -19 GSK Vir BA.2 Vir GSK Vir BA.2 79 (MHRA) -19 -19 MHRA 5
... Long COVID 1. Long COVID 763 2564 -19 Long COVID (Post COVID conditions) Long COVID 2.44-3.48 2. Long COVID Long COVID Initiative Long COVID 22,000,000 7,000,000 (Disabling Long COVID… [+16 chars]
-19 NCDs (Non-communicable diseases) ..2563 WHO (NCDs) 41 71% ..2562 76.58% 351,880 44 Health Brings Wealth 4 (Health) (Wealth) (Longevity) 4 (Prof Jií Dvoák, MD Zurich, Switzerland) , FIFA, (S… [+771 chars]
